EUVIMEDEUVIMED entdecken
Crossref

Immune Resistance Mechanisms and the Road to Personalized Immunotherapy

Miles Piper, Harriet Kluger, Eytan Ruppin, Siwen Hu-Lieskovan

American Society of Clinical Oncology Educational Book · 2023-06 · (43)

DOI: 10.1200/edbk_390290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Society of Clinical Oncology Educational Book, 2023-06. Verfasst von Miles Piper und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Utah, Salt Lake City, UT. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 210 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

What does the future of cancer immunotherapy look like and how do we get there? Find out where we've been and where we're headed in A Report on Resistance: The Road to personalized immunotherapy

Autor:innen und Institutionen

  • School of Medicine, University of Utah, Salt Lake City, UT.
  • School of Medicine, Yale University, New Haven, CT.
  • Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.

Zitieren

APA

Piper, M., Kluger, H., Ruppin, E., & Hu-Lieskovan, S. (2023). Immune Resistance Mechanisms and the Road to Personalized Immunotherapy. American Society of Clinical Oncology Educational Book. https://doi.org/10.1200/edbk_390290

Vancouver

Piper M, Kluger H, Ruppin E, Hu-Lieskovan S. Immune Resistance Mechanisms and the Road to Personalized Immunotherapy. American Society of Clinical Oncology Educational Book. 2023. doi:10.1200/edbk_390290

BibTeX
@article{Piper2023,
  author = {Piper, Miles and Kluger, Harriet and Ruppin, Eytan and Hu-Lieskovan, Siwen},
  title = {Immune Resistance Mechanisms and the Road to Personalized Immunotherapy},
  journal = {American Society of Clinical Oncology Educational Book},
  year = {2023},
  number = {43},
  doi = {10.1200/edbk_390290}
}
Kostenlos starten →